Cannabidiol Treatment in Patients With Early Psychosis

Clinical trial NCT02504151 · COMPLETED

Trial details

NCT number: NCT02504151
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2016-01-28
Primary completion: 2018-03-02
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.